Your browser doesn't support javascript.
loading
Nectin-4: a Novel Therapeutic Target for Skin Cancers.
Hashimoto, Hiroki; Tanaka, Yuka; Murata, Maho; Ito, Takamichi.
Affiliation
  • Hashimoto H; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. h-hashi@dermatol.med.kyushu-u.ac.jp.
  • Tanaka Y; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Murata M; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Ito T; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Curr Treat Options Oncol ; 23(4): 578-593, 2022 04.
Article in En | MEDLINE | ID: mdl-35312963
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Cell Adhesion Molecules / Immunoconjugates / Molecular Targeted Therapy / Antibodies, Monoclonal Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Curr Treat Options Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Cell Adhesion Molecules / Immunoconjugates / Molecular Targeted Therapy / Antibodies, Monoclonal Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Curr Treat Options Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United States